COVID-19 Updates
Latest News
As Interest From Families Wanes, Pediatricians Scale Back on COVID Shots
Pediatricians are unsure how many COVID vaccines to order as interest drops, and each shot expires in 30 days.
From the Journals
COVID-19 Booster Vaccine Shortens Menstrual Cycles in Teens
“These data are potentially important for counseling parents regarding potential vaccine refusal in the future for their teen daughters.”
Latest News
ABIM Revokes Two Physicians’ Certifications Over Accusations of COVID Misinformation
Two critical care docs lose ABIM certification following advocating for ivermectin as a treatment for COVID.
Latest News
How Safe is Anti–IL-6 Therapy During Pregnancy?
Transient neonatal cytopenia was the only possible adverse outcome that could be related to anti–IL-6 therapy.
From the Journals
Pediatric Studies Produce Mixed Messages on Relationship Between COVID and Asthma
The most recent of several studies exploring the impact of COVID-19 infection on children with asthma suggests vaccination reduces asthma symptoms...
News
The Push to Get More People Into Long COVID Studies
Websites that are easier for the layperson to access would allow for wider participation and simplified enrollment procedures would make it easier...
Conference Coverage
New mRNA Vaccines in Development for Cancer and Infections
Different forms and designations of mRNA vaccines are used, depending on the application and desired effect.
Feature
Federal Trade Commission Bans Noncompete Agreements, Urges More Protections for Healthcare Workers
But dissenting commissioners dispute the FTC’s authority to broadly ban noncompetes.
Latest News
COVID Vaccinations Less Prevalent in Marginalized Patients
Patients in the most unvaccinated group tended to live in places with more ethnic diversity, higher material deprivation, and lower incomes.
Latest News
4 Years In, a Sobering Look at Long COVID Progress
Long COVID is still a disease diagnosed by figuring out what a patient does not have. Symptom management is the only treatment now.
Latest News
Study Shows Nirmatrelvir–Ritonavir No More Effective Than Placebo for COVID-19 Symptom Relief
The drug may not be particularly helpful for patients who are not at high risk for severe COVID-19.